Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 1126 AL 1140

Paradigm shift: semantic memory decline as a biomarker of preclinical Alzheimer's disease

Venneri A, Mitolo M, De Marco M.

Biomark Med. 2016;10(1):5-8. doi: 10.2217/bmm.15.53. Epub 2015 Dec 7.

Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?

Moya-Alvarado G, Gershoni-Emek N, Perlson E, Bronfman FC.

Mol Cell Proteomics. 2016 Feb;15(2):409-25. doi: 10.1074/mcp.R115.053330. Epub 2015 Dec 11.

Toward more predictive genetic mouse models of Alzheimer's disease

Onos KD, Sukoff Rizzo SJ, Howell GR, Sasner M.

Brain Res Bull. 2016 Apr;122:1-11. doi: 10.1016/j.brainresbull.2015.12.003. Epub 2015 Dec 17.

Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease

Van Giau V, An SS.

J Neurol Sci. 2016 Jan 15;360:141-52. doi: 10.1016/j.jns.2015.12.005. Epub 2015 Dec 4.

Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease

Talwar P, Sinha J, Grover S, Agarwal R, Kushwaha S, Srivastava MV, Kukreti R.

J Neurol Sci. 2016 Jan 15;360:179-87. doi: 10.1016/j.jns.2015.12.004. Epub 2015 Dec 3.

Proteomics as an innovative tool to investigate frontotemporal disorders

Agresta AM, De Palma A, Bardoni A, Salvini R, Iadarola P, Mauri PL.

Proteomics Clin Appl. 2016 Apr;10(4):457-69. doi: 10.1002/prca.201500090. Epub 2015 Dec 10.

Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study

Boada M, Ramos-Fernández E, Guivernau B, Muñoz FJ, Costa M, Ortiz AM, Jorquera JI, Núñez L, Torres M, Páez A.

Neurologia. 2016 Sep;31(7):473-81. doi: 10.1016/j.nrl.2014.02.003. Epub 2014 Jul 9.

Factors Associated With Preferences for Institutionalized Care in Elderly Persons: Comparing Hypothetical Conditions of Permanent Disability and Alzheimer's Disease

Werner P, Segel-Karpas D.

J Appl Gerontol. 2016 Apr;35(4):444-64. doi: 10.1177/0733464814546041. Epub 2014 Sep 22.

The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease

Xia M, Cheng X, Yi R, Gao D, Xiong J.

Mol Neurobiol. 2016 Jan;53(1):455-471. doi: 10.1007/s12035-014-8994-0. Epub 2014 Dec 4.

Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies

Kamat PK, Kalani A, Rai S, Swarnkar S, Tota S, Nath C, Tyagi N.

Mol Neurobiol. 2016 Jan;53(1):648-661. doi: 10.1007/s12035-014-9053-6. Epub 2014 Dec 17.

The Effectiveness of a Culturally Sensitive Cognitive Behavioral Group Intervention for Latino Alzheimer's Caregivers

Gonyea JG, López LM, Velásquez EH.

Gerontologist. 2016 Apr;56(2):292-302. doi: 10.1093/geront/gnu045. Epub 2014 May 22.

Cognitive Domains and Health-Related Quality of Life in Alzheimer's Disease

Bosboom PR, Almeida OP.

J Gerontol B Psychol Sci Soc Sci. 2016 Mar;71(2):275-87. doi: 10.1093/geronb/gbu090. Epub 2014 Aug 5.

Changes in Sleep Predict Changes in Affect in Older Caregivers of Individuals with Alzheimer's Dementia: A Multilevel Model Approach

McCrae CS, Dzierzewski JM, McNamara JP, Vatthauer KE, Roth AJ, Rowe MA.

J Gerontol B Psychol Sci Soc Sci. 2016 May;71(3):458-62. doi: 10.1093/geronb/gbu162. Epub 2014 Nov 26.

How does a woman with Alzheimer's disease make sense of becoming cared for?

Borley G, Sixsmith J, Church S.

Dementia (London). 2016 Nov;15(6):1405-1421. doi: 10.1177/1471301214561647. Epub 2014 Dec 3.

A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments

Garrett MD, Valle R.

Dementia (London). 2016 Mar;15(2):239-54. doi: 10.1177/1471301214525166. Epub 2014 Mar 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias